The uptake of tritiated thymidine by lymphocytes from 100 cancer patients and 31 normal subjects was tested in the presence and absence of phytohaemagglutinin (PHA) in a medium containing autologous or homologous serum. Significant differences were found between normal subjects and cancer patients in both the time course and degree of uptake. Serum from normal individuals restored the response of lymphocytes from cancer patients towards normality whilst serum from other cancer patients had no effect. Serum from cancer patients impaired the response of normal lymphocytes.
It has been suggested that cellular immune potential in man and animals may be assessed by measuring the capability of small lymphocytes to transform in the presence ofPHA (Bloom, 1971) . There are several reports that this is impaired in certain diseases including cancer (Gatti, 1971) . The reason for the impairment of transformation in cancer patients has been attributed either to abnormality of the lymphocytes-or to the presence of inhibitors in sera. The transformation of lymphocytes from healthy individuals has been shown to be reduced by incubation with sera from cancer patients (Silk, 1967; Whittaker, Rees, and Clark, 1971 ). Other workers have failed to detect inhibitors and some have even described stimulatory factors in the sera of patients with cancer (Kasakura and Lowenstein, 1967; Golob, Israsena, Quatrale, and Becker, 1969; Al-Sarraf and Vaitkevicius, 1971) .
Recently there has been evidence that PHAinduced transformation of lymphocytes may be influenced by a number of factors apart from the presence or absence of disease, eg, general anaesthetics (Park, Brody, Wallace, and Blakefore, 1971) , day-to-day spontaneous variation (McIntyre and Cole, 1969) , and differences in technique such as varying periods of incubation (Bredt and Mardiney, 1969; McIntyre and Cole, 1969; Nelson, 1969; Park et al, 1971 ) and concentrations of PHA (Ducos, Migueres, Colombies, Kessous, Poujoulet, 1970; Carr and Stites, 1972) . Any investigation involving so many variables requires a large series of cases. However, only small numbers of cancer patients have Received for publication 29 May 1973. been studied in each of the reported series. In the present investigation, lymphocytes from 100 cancer patients and 31 healthy individuals were cultured for up to 168 hours in a medium containing either autologous or homologous serum, with or without PHA. The cancer patients were divided into three groups depending on whether the lymphocytes were obtained (a) before operation, (b) within one year after operation, (c) more than one year after operation.
Materials and Methods
Blood was obtained by venepuncture from 31 healthy individuals and from 100 cancer patients. None of the patients had received radiotherapy. None had received chemotherapy within two weeks of taking the blood sample. The patients included both children and adults suffering from a wide variety of tumours as shown in The responses of cancer patients' lymphocytes cultured without PHA follow a similar, though much lower, pattern when compared with the corresponding PHA-stimulated group. It is possible that the transformation seen in the absence of PHA in our study might have been due to the presence of antibiotics and the serum-gelatin mixture in the culture media.
In the present study incubation of lymphocytes derived from healthy donors and cancer patients in autologous and homologous sera supports the contention that the sera from cancer patients significantly depresses the ability of healthy lymphocytes to transform and the addition of sera from healthy individuals improves the response of cancer patients' lymphocytes. The addition of homologous healthy serum to the medium failed to alter the responses of healthy lymphocytes. Similarly, the addition of homologous cancer serum to cultures of cancer patients' lymphocytes had no effect. The nature of the serum inhibitors is not known; an a2-globulin (Cooperband, Bondevik, Schmid, and Mannick, 1968) , polypeptide (Scheurlen, Schneider, and Pappas) , and IgG (Barnes, Bishun, and Holliday, 1970) have been suggested. It is also possible that there is a lack of growth-stimulating factor in the sera of cancer patients.
The relevance of the depressed lymphocyte transformation and the inhibitory action of cancer patients serum on autologous and homologou s lymphocytes is problematical. Whether it represents partial failure of immunological surveillance and hence might be important aetiologically or is a result of the disease state could only be satisfactorily solved by a long-term prospective study. That the abnormality demonstrated preoperatively tends towards normality in lymphocytes from patients some time postoperatively suggests a tumour-dependent effect rather than an aetiological factor.
